Related Experiment Video

Updated: May 25, 2026

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Published on: December 27, 2024

Retinoid receptors and therapeutic applications of RAR/RXR modulators

Albane le Maire1, Susana Alvarez, Pattabhiraman Shankaranarayanan

  • 1Institut National de la Santé et de la Recherche Médicale, U1054, Montpellier, France.

Current Topics in Medicinal Chemistry
|January 17, 2012
PubMed

Insights

Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are key drug targets. Designing selective ligands for these nuclear receptors offers new therapeutic strategies for cancer and metabolic diseases.

Area of Science:

  • Molecular biology
  • Pharmacology
  • Drug discovery

Background:

  • Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are nuclear receptors crucial for regulating cell growth, differentiation, survival, and death.
  • These receptors form heterodimers and are significant drug targets for treating cancer and metabolic diseases.

Purpose of the Study:

  • To outline strategies for designing selective RAR and RXR modulators.
  • To review the structural mechanisms underlying how different pharmacological compounds modulate receptor functions.
  • To discuss the future potential of retinoid- and rexinoid-based therapies.

Main Methods:

  • Design and synthesis of selective RAR and RXR ligands.
  • Structural and functional analyses of ligand-receptor interactions.
  • Review of existing literature on retinoid and rexinoid pharmacology.

Main Results:

  • Extensive libraries of RAR- and RXR-selective ligands, including agonists, antagonists, and inverse agonists, have been developed.
  • Structural studies reveal how ligands induce allosteric conformational changes, modulating coregulator interactions.
  • Understanding these mechanisms provides insight into the molecular basis of ligand action.

Conclusions:

  • Selective modulation of RARs and RXRs presents promising therapeutic avenues.
  • Further research into retinoid and rexinoid-based therapies holds significant potential for various diseases.
  • Targeted drug design based on structural insights can optimize therapeutic outcomes.

More Related Videos

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation09:07

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation

Published on: June 21, 2016

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Reticular Dermis01:15

Reticular Dermis

The papillary and reticular dermis are the two layers of the dermis. They are made of connective tissue with fibers of collagen extending from one to the other, making the border between the two somewhat indistinct. The dermal papillae extending into the epidermis belong to the papillary layer, whereas the dense collagen fiber bundles below belong to the reticular layer.
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...